Abstract
The application of nanotechnology to dermatology has opened new doors in the diagnosis and treatment of cutaneous malignancies in the twenty-first century. Noninvasive diagnosis of cutaneous malignancies has traditionally been limited by the confines of what can be seen with visual inspection. Despite the availability of adjunctive tools, such as the dermatoscope, to increase accuracy in correct identification of lesions, skin biopsy with histopathologic confirmation is frequently necessary to ascertain a diagnosis. Thus, the possibility of imaging potentially malignant lesions noninvasively by coupling nanotechnology with various imaging techniques is very exciting. Much of this new technology still remains under investigation. This chapter will provide an overview of cutaneous malignancies, as well as an overview of the traditional methods and current developments in cutaneous imaging on the nanotechnology front.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
Kim RH, Armstrong AW. Nonmelanoma skin cancer. Dermatol Clin. 2012;30:125–39, ix
Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146 Suppl 61:1–6.
Weinstock MA, Bogaars HA, Ashley M, Litle V, Bilodeau E, Kimmel S. Nonmelanoma skin cancer mortality. A population-based study. Arch Dermatol. 1991;127:1194–7.
Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7.
Tuong W, Cheng LS, Armstrong AW. Melanoma: epidemiology, diagnosis, treatment, and outcomes. Dermatol Clin. 2012;30:113–24, ix.
Erickson C, Driscoll MS. Melanoma epidemic: facts and controversies. Clin Dermatol. 2010;28:281–6.
Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129:1666–74.
Robinson JK, Rigel DS, Amonette RA. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol. 1997;37:179–86.
Wolff K, Johnson RA. Cutaneous melanoma. In: Sydor AM, Englis MR, editors. Fitzpatrick’s color atlas & synopsis of clinical dermatology. 6th ed. New York, NY: McGraw Hill Medical; 2009. p. 308–27.
Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol. 2002;20:297–304.
Argenziano G, Ferrara G, Francione S, Di Nola K, Martino A, Zalaudek I. Dermoscopy–the ultimate tool for melanoma diagnosis. Semin Cutan Med Surg. 2009;28:142–8.
Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35:433–44.
El Tal AK, Abrou AE, Stiff MA, Mehregan DA. Immunostaining in Mohs micrographic surgery: a review. Dermatol Surg. 2010;36:275–90.
Smith L, Macneil S. State of the art in non-invasive imaging of cutaneous melanoma. Skin Res Technol. 2011. doi:doi: 10.1111/j.1600-0846.2011.00503.x.
Monheit G, Cognetta AB, Ferris L, et al. The performance of MelaFind: a prospective multicenter study. Arch Dermatol. 2011;147:188–94.
Zuo L, Wei W, Morris M, Wei J, Gorbounov M, Wei C. New technology and clinical applications of nanomedicine. Med Clin North Am. 2007;91:845–62.
Li Z, Huang P, Lin J, et al. Arginine-glycine-aspartic acid-conjugated dendrimer-modified quantum dots for targeting and imaging melanoma. J Nanosci Nanotechnol. 2010;10:4859–67.
Nair A, Shen J, Thevenot P, et al. Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles. Nanotechnology. 2008;19:485102.
Zhang Q, Iwakuma N, Sharma P, et al. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography. Nanotechnology. 2009;20:395102.
Aillon KL, Xie Y, El-Gendy N, et al. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009;61(6):457–66.
Kim C, Cho EC, Chen J, et al. In vivo molecular photoacoustic tomography of melanomas targeted by bio conjugated gold nanocages. ACS Nano. 2010;4(8):4559–64.
Schmieder AH, Winter PM, Caruthers SD, et al. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med. 2005;53:621–7.
Longo C, Gambara G, Espina V, et al. A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum. Exp Dermatol. 2011;20:29–34.
Nasir A. Nanotechnology and dermatology: part I–potential of nanotechnology. Clin Dermatol. 2010;28:458–66.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kim, J.K., Nasir, A., Nelson, K.C. (2013). Nanotechnology and the Diagnosis of Cutaneous Malignancies. In: Nasir, A., Friedman, A., Wang, S. (eds) Nanotechnology in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5034-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5034-4_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5033-7
Online ISBN: 978-1-4614-5034-4
eBook Packages: MedicineMedicine (R0)